Here are the 8-K filings from First Choice Hlthcre Inc (FCHS) in our archive since June 2025, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
An 8-K covers material events a company has to report between its quarterly reports, so if you follow FCHS and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full FCHS filings page.
First Choice Healthcare Solutions, Inc. (symbol: FCHS) is the issuer of record for a Form 8-K filing submitted to the SEC.
First Choice Healthcare Solutions, Inc. entered into a Business Combination Agreement with Westin Acquisition Corp., a Nasdaq-listed SPAC, and a merger subsidiary to create a publicly traded healthcare and wellness company. Westin will first domesticate from the Cayman Islands to Nevada as “Wellgevity 360, Inc.” (“PubCo”), after which the merger subsidiary will merge into First Choice, leaving First Choice as a wholly owned subsidiary of PubCo.
The transaction implies a pre-money equity value of up to approximately $650 million for First Choice, payable in PubCo common stock based on an equity-value-to-redemption-price formula. Each share of First Choice common (and any preferred) stock, other than excluded or dissenting shares, will convert into PubCo shares, with Company equity awards handled under the agreement. Concurrently, First Choice signed agreements to acquire the Pointe Med Entities, expected to close substantially concurrently with the business combination, and secured a PIPE investment in PubCo preferred stock with an aggregate stated value of $12,500,000 for a $10,000,000 purchase price at closing.
Closing is subject to SEC effectiveness of a Form S-4 registration statement, Nasdaq listing approval for PubCo shares, required shareholder consents, absence of specified material adverse effects and regulatory issues, and substantially simultaneous completion of the Pointe Med acquisitions. The agreement includes customary termination rights, including if closing has not occurred by March 31, 2027 (subject to automatic extension to April 30, 2027 in certain SEC-review circumstances). Post-closing, PubCo’s initial board is expected to have five directors, a majority independent, with one designated by the SPAC sponsor and three plus the CEO designated by First Choice, alongside lock-up and registration rights arrangements for key holders.